Similarly, patients with high basal or induced IFN-γ scores had a better immune response [52], and PD-L1 levels and enrichment of interferon signatures in melanoma samples were correlated with patient response to anti-PD-1 immunotherapy [57]. This evidence concerns the gene IFNG and melanoma.